Fig. 2From: Reductions in AFP and PIVKA-II can predict the efficiency of anti-PD-1 immunotherapy in HCC patientsReceiver operating characteristics curves of AFP reduction, PIVKA-II reduction and the AAP score for identifying response (CR + PR) of HCC patients treated with anti-PD-1 immunotherapyBack to article page